Ryman Healthcare posts 10% rise in retirement living sales
Make us a preferred source
Make us a preferred source on Google
The news: Ryman Healthcare has reported 331 sales of retirement living occupation right agreements (ORAs) for the fourth quarter, reflecting a 10% increase on the prior corresponding quarter, but down from 375 sales in third quarter.
The numbers: Ryman reported total sales of 1,410 ORAs, including 348 new sales and 1,062 resales in FY26.
Sales volumes include 39 retirement living resident relocations from Margaret Stoddart and Woodcote villages as their primary care centres closed during the year.
Excluding the relocations, total sales came to 1,371, in line with Ryman’s guidance provided at its half-year results.
Mature care centre occupancy was sustained at 96.1% in the fourth quarter, with developing care centres rising above an 80% occupancy rate as at 31 March.
The context: Ryman attributed the lower resale volumes to decreased internal transfers.
The retirement village operator said the ongoing Middle East conflict had not impacted the broader business to date, however it is closely watching for potential pressure from inflation and interest rates on the real estate market.
Ryman expects its free cashflow to be around NZD180 million ($149 million) in FY26. It is scheduled to report its FY26 earnings results on 26 May 2026.
What they said: "We’re pleased with our final quarter trading results and encouraged by sustained improvement across lead indicators, including net sales applications exceeding turnover levels for the first time since we made changes to our contract terms in late 2024,” CEO Naomi James said.
The source: ASX
